References
1. Fukazawa R, Kobayashi J, Ayusawa M,
Hamada H, Kimura T. Jcs/jscs 2020 guideline on diagnosis and management
of cardiovascular sequelae in kawasaki disease. Circulation
Journal . 2020
2. Kobayashi T, Kobayashi T, Morikawa
A, Ikeda K, Seki M, Shimoyama S, et al. Efficacy of intravenous
immunoglobulin combined with prednisolone following resistance to
initial intravenous immunoglobulin treatment of acute kawasaki disease.J Pediatr . 2013;163:521-526
3. Son MBF, Kimberlee G, Lin M, Baker
AL, Sundel RP, Fulton DR, et al. Treatment of kawasaki disease: Analysis
of 27 us pediatric hospitals from 2001 to 2006. Pediatrics .
2009;124:1-8
4. Levi M, Poll TVD, Cate HT, Deventer
SJHV. The cytokine-mediated imbalance between coagulant and
anticoagulant mechanisms in sepsis and endotoxaemia. European
Journal of Clinical Investigation . 1997
5. Takayuki O, Yoshihiko N, Kunihiko
T, Kazuki N, Daisuke K, Shigeyuki M. Treatment of patients with sepsis
in a closed intensive care unit is associated with improved survival: A
nationwide observational study in japan. Journal of Intensive
Care . 2018;6:57-
6. Dhar, J. P, Andersen, J.,
Essenmacher, L., et al. Thrombophilic patterns of coagulation factors in
lupus. Lupus . 2009
7. Newburger JW, Takahashi M, Gerber
MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and
long-term management of kawasaki disease: A statement for health
professionals from the committee on rheumatic fever, endocarditis, and
kawasaki disease, council on cardiovascular disease in the young,
american heart association. Pediatrics . 2004;114:1708-1733
8. Mauro P, Lucia Z, Camilla LA,
Massimo C, Boscolo AM, Rossella B, et al. Assessment of fibrinolysis in
sepsis patients with urokinase modified thromboelastography. Plos
One . 2015;10:e0136463
9. Hypercoagulation and elevation of
blood triglycerides are characteristics of kawasaki disease.Lipids in Health & Disease . 2015;14:166
10. Levi M, Keller T, van Gorp E, ten
Cate H. Infection and inflammation and the coagulation system.Cardiovascular research . 2003;60:26-39
11. Principi N, Rigante D, Esposito
S. The role of infection in kawasaki syndrome. Journal of
Infection . 2013;67:1-10
12. Shao S, Luo C, Zhou K, Hua Y,
Wang C. Predictive value of serum procalcitonin for both initial and
repeated immunoglobulin resistance in kawasaki disease: A prospective
cohort study. Pediatric Rheumatology . 2019;17:78
13. AM vR, RW W, AM O-M.
Procalcitonin as an early marker of infection in neonates and children.The Lancet. Infectious diseases . 2004;4:620-630
14. Foley JH, Conway EM. Cross talk
pathways between coagulation and inflammation. Circulation
Research . 2016;118:1392-1408
15. Sigurdur B, Claudia H, Attila F,
Thomas K. Coagulation tests on admission correlate with mortality and
morbidity in general icu patients: An observational study. Acta
anaesthesiologica Scandinavica . 2020;2020年64卷5期:628-634页
16. Loizou E, Mayhew D, Martlew V,
Murthy B. Implications of deranged activated partial thromboplastin time
for anaesthesia and surgery. Anaesthesia . 2018;73:1557-1563
17. Aird, William C. Vascular
bed-specific hemostasis: Role of endothelium in sepsis pathogenesis.Critical Care Medicine . 2001;29:34-35
18. Huang X, Shen H, Li M. Protective
and pathological roles of tissue factor in the heart.Hmostaseologie . 2015;35:37-46
19. Rezaie AR, Giri H. Anticoagulant
and signaling functions of antithrombin. Journal of Thrombosis and
Haemostasis . 2020
20. Mikkel, Allingstrup, Jørn,
Wetterslev, Frederikke, B., et al. Antithrombin iii for critically ill
patients: A systematic review with meta-analysis and trial sequential
analysis. Intensive Care Medicine . 2016
21. Levi M, Poll TVD. Two-way
interactions between inflammation and coagulation. Trends in
Cardiovascular Medicine . 2005;15:254-259
22. Xie Y, Tian R, Jin W, Xie H, Wang
R. A prediction model of sepsis-associated acute kidney injury based on
antithrombin iii. Ssrn Electronic Journal . 2020
23. Levi M, van der Poll T. The role
of natural anticoagulants in the pathogenesis and management of systemic
activation of coagulation and inflammation in critically ill patients.Seminars in thrombosis and hemostasis . 2008;34:459-468
24. Chen R, Doolittle RF. -
cross-linking sites in human and bovine fibrin. Biochemistry .
1971;10:4487-4491
25. Kogan A, Mukharyamova K,
Bereznikova A, Filatov V, Koshkina E, Bloshchitsyna M, et al. Monoclonal
antibodies with equal specificity to d-dimer and high-molecular-weight
fibrin degradation products. Blood coagulation & fibrinolysis :
an international journal in haemostasis and thrombosis . 2016;27:542-550
26. Liu J, Wang H, Huang Z, Tao X, Li
J, Hu Y, et al. Risk factors and outcomes for carbapenem-resistant
klebsiella pneumoniae bacteremia in onco-hematological patients.Journal of infection in developing countries . 2019;13:357-364
27. Levi M, Schultz M, Poll TVD.
Disseminated intravascular coagulation in infectious disease.Seminars in Thrombosis & Hemostasis . 2010;36
28. Mcever RP. Gmp-140: A receptor
for neutrophils and monocytes on activated platelets and endothelium.Journal of Cellular Biochemistry . 1991
29. Shorr AF, Thomas SJ, Alkins SA,
Fitzpatrick TM, Ling GS. D-dimer correlates with proinflammatory
cytokine levels and outcomes in critically ill patients*. Chest .
2002;121:1262-1268